Johnson & Johnson is now testing itsvaccine on teenagers, the pharmaceutical company stated on Friday.
The drugmaker has been conducting a medical trial wanting on the security and immune response of its vaccine on wholesome adults since September. That ongoing research now contains adolescents 12 to 17 years of age, in accordance with J&J.
Dr. Paul Stoffels, vice chairman of the chief committee and chief scientific officer at J&J, famous the pandemic’s “profound impact” on the schooling, psychological well being and well-being of adolescents. “It is vital that we develop vaccines for everyone, everywhere, to help combat the spread of the virus with the goal to return to everyday life,” he stated in a press release.
Dr. Anthony Fauci, the chief medical adviser to the White House, not too long agofor older kids within the fall, however in all probability will not be out there till 2020 for elementary school-aged youngsters.
J&J’s vaccine will initially be examined in a small variety of teenagers, 16- to 17-years-old, then expanded to a bigger group of youthful adolescents, the company stated. The trial is now enrolling individuals in Spain and the United Kingdom, and shortly will embrace individuals within the U.S., Netherlands and Canada, with individuals in Brazil and Argentina to observe, the company stated.
J&J can be in discussions with well being authorities “to initiate studies in pregnant women and children in the near future.” in accordance with Dr. Mathai Mammen, international head, Janssen analysis and growth at J&J.
The company’s announcement comes days after J&Jmade by a contractor couldn’t be used as a result of it hadn’t met high quality management requirements. J&J nonetheless plans to ship 100 million doses in each May and June.